Pharmafile Logo

JMC Partners LLP

JMC Partners is an established communications consultancy, with a particular expertise in healthcare. We have an excellent record of informing and influencing public policy on behalf of our clients. In a constantly evolving public policy environment, we work together with our clients to help them navigate the political process and convey their message to the people that count in Westminster and beyond. Our dedicated team provides a truly personalised service based on a genuine understanding of our clients’ goals and aspirations. We pride ourselves on the relationships we build and the results we achieve.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Visions4Health

Visions4Health are market access experts and your gateway to local adoption at pace. Leveraging our lived experience, understanding of national and local healthcare systems, and insights generated by our stakeholder…

View Profile

Company Details

Hudson House, 8 Tavistock Street, London, WC2E 7PP, United Kingdom
020 3178 7569

 Latest Content from PMHub 

Say Wins Communiqué Agility, Flexibility And Transformation Award For Corporate Comms During Geopolitical Upheaval

SAY took home the Agility, Flexibility and Transformation Award at the prestigious Communiqué Awards on 4 July 2024 in recognition of the communications support provided The Royal College of Occupational...

Compliance — a driving force for influencing public perceptions of the pharma industry?

How does compliance play into public perceptions of pharma and why is it important for improving public opinion?

Oxford PharmaGenesis welcomes Christopher Rains on board as our first Non-Executive Director

Oxford PharmaGenesis is proud to announce the appointment of Christopher Rains as our first Non-Executive Director, strengthening the Board with over 30 years of experience in the pharmaceutical industry. A...

Online Investigator Meetings: A Customer Story

Discover how Impetus Digital transformed a multicenter Phase III clinical trial with their innovative virtual solutions.

Medscape Education Showcases Unprecedented Achievements at EHA 2024

Medscape Education is proud to share its monumental success at the EHA 2024 Congress. Our continued commitment to patient-centric medical education was evident throughout the event, with notable achievements and...

Why a LinkedIn short video feed is so exciting for healthcare comms

LinkedIn has confirmed that it’s currently experimenting with a short video feed, TikTok-style. This has rather split opinion online, with some seeing it as a mix that won’t work, while...

Reaching Women Where They’re At: Setting Up a Safe Space for HIV Prevention Conversations

“I always enjoyed solving problems and putting puzzles together,” says Harmony Garges, MD, CMO at ViiV Healthcare and a pediatric infectious disease specialist. “So for me, infectious disease was a...

The MM+M Agency 100 report: Oxford PharmaGenesis is recognized as an industry leader for the fourth year running

For the fourth year running, media brand Medical Marketing and Media (MM+M) has listed Oxford PharmaGenesis in its Agency 100 report – the annual definitive ‘who’s who’ ranking of the...

Medscape Education Demonstrates Strong Education Outcomes at the American Diabetes Association 2024 Conference

Medscape Education presented seven scientific posters at this year’s American Diabetes Association (ADA) conference in Orlando, Florida. These posters highlighted the outcomes of Medscape Education’s continuing medical education programs, which...

Mobile Flexibility – Perks of Virtual Medical Education

Unlock the potential of virtual collaboration with mobile flexibility! Discover how the latest technologies enable you to engage in medical education and collaborate from any corner of the globe. Watch...